CN1403120A - Yusanxiao medicine for treating diabetes and its prepn - Google Patents
Yusanxiao medicine for treating diabetes and its prepn Download PDFInfo
- Publication number
- CN1403120A CN1403120A CN 02133230 CN02133230A CN1403120A CN 1403120 A CN1403120 A CN 1403120A CN 02133230 CN02133230 CN 02133230 CN 02133230 A CN02133230 A CN 02133230A CN 1403120 A CN1403120 A CN 1403120A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- yusanxiao
- angelicae sinensis
- rhizoma coptidis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind of Chinese medicine preparation, and is one kind of medicine for treating diabetes, named Yusanxiao, and its preparation. The Chinese medicine preparation is prepared with 17 kinds of Chinese medicinal materials including astragalus root, rehmannia root, prepared rhizome of rehmannia, ophiopogon root, aspharagus root, etc. and through separate crushing, decoction, concentration, merging, pelletizing, drying, packing and other steps. It has excellent blood sugar reducing function and has stable curative effect, no influence to heart, liver and kidney and no toxic side effect.
Description
Technical field: the present invention relates to a kind of Chinese medicine preparation, promptly treat the Yusanxiao medicine and the preparation method of diabetes.
Background technology: in prior art, to treatment of diabetes, effectively control of diabetes patient's blood sugar level of many medicines is arranged clinically, as diabetes pill, its shortcoming is that curative effect is general.
Summary of the invention: the Yusanxiao medicine and the preparation method that the objective of the invention is to provide a kind of treatment diabetes evident in efficacy at above-mentioned deficiency.
Technical solution of the present invention is: a kind of Yusanxiao medicine for the treatment of diabetes, and it is made by the raw material of following weight:
Radix Astragali 192-288g, Radix Rehmanniae 154-216g, Radix Rehmanniae Preparata 96-144g, Radix Ophiopogonis 48-72g, Radix Asparagi 48-72g, Radix Scrophulariae 96-144g, Fructus Schisandrae Chinensis 48-72g, Herba Epimedii 96-144g, Radix Salviae Miltiorrhizae 96-144g, Flos Carthami 96-144g, Radix Angelicae Sinensis 48-72g, Rhizoma Coptidis 8-12g, Radix Ginseng Rubra 37-55g, Cornu Cervi Pantotrichum 3-6g, Rhizoma Anemarrhenae 96-144g, Radix Codonopsis 108-160g, Radix Trichosanthis 96-144g.Be preferably capsule preparations.Also each medicinal component and pharmaceutical carrier or additive are mixed and made into common dosage forms in the pharmacy such as tablet, pill, electuary, oral liquid, granule.
Treatment is quenched one's thirst should be with YIN nourishing and the production of body fluid promoting, and benefiting QI for activating blood circulation is main, so mend congenital cloudy hemopoietic spermatogenesis benefit marrow to give birth to ripe two Radix Rehmanniae in the side; Select the Radix Astragali to mend the gas of the day after tomorrow, yang invigorating shape stagnates; Use the Radix Asparagi and Radix Ophiopogonis born fluid, fall asthenic fire, help to foster the moon, hinder with the restless with anxiety of transferring three types of diabetes; Adopt Radix Trichosanthis etc. and promote the production of body fluid and moisturize, go into the Five Classics and the capable three warmers of cloth.This side's using medicines of both cold and hot natures simultaneously, mutual aid gas is cloudy deficient, the disease of deficiency of both YIN and YANG is obviously induced the insulin secretion of human body self, and can be by the comprehensive Accommodation of Chinese medicine, increase the sensitivity of human body to insulin, minimizing is to the opposing of insulin, and the enhancing body cell promotes the metabolism of glucose in the blood to the transhipment of glucose, reduce and stable blood glucose, fundamentally overcome only simple in the past insulin secretion or the outside drawback of curing the symptoms, not the disease of supplying with the insulin blood sugar lowering of trust of increasing.
Preparation method: the Cornu Cervi Pantotrichum list is ground into fine powder; Radix Angelicae Sinensis, Rhizoma Coptidis, red ginseng powder are broken into fine powder; 13 flavor medicines such as all the other Radix Rehmanniae decoct with water secondary, and each 2 hours, gradation was filtered, merging filtrate, be concentrated into thick paste shape (relative density is 1.84) and mix with above-mentioned Radix Angelicae Sinensis, Rhizoma Coptidis, Radix Ginseng Rubra fine powder, drying, pulverizing, adding velvet powder, mixing, granulation, drying, packing are promptly.
Function cures mainly: YIN nourishing and the production of body fluid promoting, benefiting QI for activating blood circulation.Being used for light, moderate II type diabetes belongs to deficiency of both QI and YIN and holds stasis of blood disease person under the arm.Disease is seen: thirst and liking drink, and easy hungry polyphagia, lassitude and weak, the spontaneous sweating dark tongue quality has ecchymosis, thready and rapid pulse etc.
Usage and dosage: with the capsule preparations is example, and ante cibum is oral, one time 8 (0.4g), 3 times on the one.3 months courses of treatment or follow the doctor's advice.
Advantage of the present invention is: 1, this medicine adopts Chinese medicine fully, does not have other any additional composition.Can not only improve polydipsia, polyphagia, polyuria symptom such as become thin effectively, can also across-the-board regulation human body carbohydrate metabolism function, promote the normal carbohydrate metabolism of body recovery, not only take stopgap measures but also effect a permanent cure, more can effectively prevent diabetes to the development of frequently-occurring diseases such as severe infections, cardio cerebrovascular affection, nephropathy change, neuropathy and cataract of eyes, thereby improve quality of life.2, this medicine Attached Hospital, Changchun Chinese Medicinal College in numerous clinical hospitals shows to have good blood sugar reducing function to 50 routine diabetes type of deficiency of both QI and YIN patient clinical observations, and its aggregate efficiency 92% is apparently higher than matched group.Through the prompting of glycolated hemoglobin testing result, the effect of this medicine blood sugar lowering rate is stable.Simultaneously to many clinical manifestations of diabetics effect that also has clear improvement.Treat forward and backward conscience of carrying out, the kidney function test result also shows, taking more, three capsule for eliminating do not have influence to above-mentioned vitals, only the small number of patients random thoughts are felt sick, epigastric discomfort, adapt to the back Lock-out, illustrate three capsule for eliminating more be a safety, effectively, stable curative effect, the blood sugar lowering new drug that has no side effect, have the clinical development using value, be worthy of popularization.3, feasible process, drug effect is definite.
Below in conjunction with embodiment the present invention is described in further detail:
The specific embodiment:
Embodiment 1: three capsule for eliminating more: Radix Astragali 240g, Radix Rehmanniae 180g, Radix Rehmanniae Preparata 120g, Radix Ophiopogonis 60g, Radix Asparagi 60g, Radix Scrophulariae 120g, Fructus Schisandrae Chinensis 60g, Herba Epimedii 120g, Radix Salviae Miltiorrhizae 120g, Flos Carthami 120g, Radix Angelicae Sinensis 60g, Rhizoma Coptidis 10g, Radix Ginseng Rubra 46g, Cornu Cervi Pantotrichum 4.6g, Rhizoma Anemarrhenae 120g, Radix Codonopsis 134g, Radix Trichosanthis 120g.
Embodiment 2: three capsule for eliminating more: Radix Astragali 260g, Radix Rehmanniae 170g, Radix Rehmanniae Preparata 100g, Radix Ophiopogonis 50g, Radix Asparagi 50g, Radix Scrophulariae 100g, Fructus Schisandrae Chinensis 50g, Herba Epimedii 130g, Radix Salviae Miltiorrhizae 130g, Flos Carthami 130g, Radix Angelicae Sinensis 50g, Rhizoma Coptidis 10g, Radix Ginseng Rubra 50g, Cornu Cervi Pantotrichum 4.6g, Rhizoma Anemarrhenae 100g, Radix Codonopsis 140g, Radix Trichosanthis 100g.
Preparation method: the Cornu Cervi Pantotrichum list is ground into fine powder; Radix Angelicae Sinensis, Rhizoma Coptidis, red ginseng powder are broken into fine powder; 13 flavor medicines such as all the other Radix Rehmanniae decoct with water secondary, and each 2 hours, gradation was filtered, merging filtrate, be concentrated into thick paste shape (relative density is 1.84) and mix with above-mentioned Radix Angelicae Sinensis, Rhizoma Coptidis, Radix Ginseng Rubra fine powder, drying, pulverizing, adding velvet powder, mixing, granulation, drying, packing are promptly.
Claims (5)
1, a kind of Yusanxiao medicine for the treatment of diabetes is characterized in that it is made by the raw material of following weight:
Radix Astragali 192-288g, Radix Rehmanniae 154-216g, Radix Rehmanniae Preparata 96-144g, Radix Ophiopogonis 48-72g, Radix Asparagi 48-72g, Radix Scrophulariae 96-144g, Fructus Schisandrae Chinensis 48-72g, Herba Epimedii 96-144g, Radix Salviae Miltiorrhizae 96-144g, Flos Carthami 96-144g, Radix Angelicae Sinensis 48-72g, Rhizoma Coptidis 8-12g, Radix Ginseng Rubra 37-55g, Cornu Cervi Pantotrichum 3-6g, Rhizoma Anemarrhenae 96-144g, Radix Codonopsis 108-160g, Radix Trichosanthis 96-144g.
2,, it is characterized in that making capsule according to the Yusanxiao medicine of the described treatment diabetes of claim 1.
3, according to the Yusanxiao medicine of the described treatment diabetes of claim 2, it is characterized in that optimization formula is: Radix Astragali 240g, Radix Rehmanniae 180g, Radix Rehmanniae Preparata 120g, Radix Ophiopogonis 60g, Radix Asparagi 60g, Radix Scrophulariae 120g, Fructus Schisandrae Chinensis 60g, Herba Epimedii 120g, Radix Salviae Miltiorrhizae 120g, Flos Carthami 120g, Radix Angelicae Sinensis 60g, Rhizoma Coptidis 10g, Radix Ginseng Rubra 46g, Cornu Cervi Pantotrichum 4.6g, Rhizoma Anemarrhenae 120g, Radix Codonopsis 134g, Radix Trichosanthis 120g.
4,, it is characterized in that each medicinal component also can be mixed and made into common dosage forms in the pharmacy such as tablet, pill, electuary, oral liquid, granule with pharmaceutical carrier or additive according to the Yusanxiao medicine of the described treatment diabetes of claim 1.
5, a kind of preparation method for preparing the described medicine of claim 2 is characterized in that method for making is as follows:
The Cornu Cervi Pantotrichum list is ground into fine powder; Radix Angelicae Sinensis, Rhizoma Coptidis, red ginseng powder are broken into fine powder; 13 flavor medicines such as all the other Radix Rehmanniae decoct with water secondary, and each 2 hours, gradation was filtered, merging filtrate, and being concentrated into the thick paste shape mixes with above-mentioned Radix Angelicae Sinensis, Rhizoma Coptidis, Radix Ginseng Rubra fine powder, drying, pulverizing, adding velvet powder, mixing, granulation, drying, packing are promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02133230 CN1403120A (en) | 2002-10-18 | 2002-10-18 | Yusanxiao medicine for treating diabetes and its prepn |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02133230 CN1403120A (en) | 2002-10-18 | 2002-10-18 | Yusanxiao medicine for treating diabetes and its prepn |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1403120A true CN1403120A (en) | 2003-03-19 |
Family
ID=4747102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02133230 Pending CN1403120A (en) | 2002-10-18 | 2002-10-18 | Yusanxiao medicine for treating diabetes and its prepn |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1403120A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100391485C (en) * | 2005-12-24 | 2008-06-04 | 郭海明 | Medicine for treating diabetes and its preparation method |
CN101279034B (en) * | 2008-05-28 | 2010-08-18 | 贾宏雄 | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof |
CN101229305B (en) * | 2007-12-27 | 2012-12-19 | 高培雄 | Process for fabricating hypoglycemic capsule |
CN103623204A (en) * | 2013-12-19 | 2014-03-12 | 杨洪恩 | Traditional Chinese medicine for treating diabetes mellitus |
-
2002
- 2002-10-18 CN CN 02133230 patent/CN1403120A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100391485C (en) * | 2005-12-24 | 2008-06-04 | 郭海明 | Medicine for treating diabetes and its preparation method |
CN101229305B (en) * | 2007-12-27 | 2012-12-19 | 高培雄 | Process for fabricating hypoglycemic capsule |
CN101279034B (en) * | 2008-05-28 | 2010-08-18 | 贾宏雄 | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof |
CN103623204A (en) * | 2013-12-19 | 2014-03-12 | 杨洪恩 | Traditional Chinese medicine for treating diabetes mellitus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
CN102908599A (en) | Medicine capable of reducing blood sugar, blood fat and blood pressure | |
CN101642529B (en) | Preparation capable of treating diabetes | |
CN1895547B (en) | Medicine for treating diabetes and its preparation | |
CN1899455B (en) | External use plaster for treating child heat diarrhea and preparing method | |
CN101513492A (en) | Chinese medicament for treating diabetes | |
CN102018852B (en) | Ginseng and coptis capsule for quenching thirsty and reducing blood sugar and preparation process | |
CN1403120A (en) | Yusanxiao medicine for treating diabetes and its prepn | |
CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
CN101843843A (en) | Chinese medicament for treating diabetes | |
CN101843747B (en) | Chinese medicament for treating rheumatoid arthritis | |
CN101732455A (en) | Medicament for treating chronic hepatitis | |
CN101601794A (en) | The hypoglycemic and thirst-relieving Chinese medicine preparation | |
CN103191293B (en) | Sub-health-preventive drug composition and preparation method thereof | |
CN101919973A (en) | Traditional Chinese medical nephritis alleviating tablet for treating nephritis | |
CN101357187A (en) | Medicine for treating the prostatitis | |
CN100398123C (en) | Medicine for treating diabetes of blood stasis complicated kidney spleen deficiency type | |
CN107596327A (en) | A kind of medicine for treating intermingling cold and heat functional dyspepsia FD | |
CN101843775A (en) | Chinese medicament for treating diabetic nephropathy | |
CN1306830A (en) | Medicine for treating type II diabetes | |
CN102266417B (en) | Chinese medicine for treating acquired immune deficiency syndrome and preparation method and administration method thereof | |
CN101385838B (en) | Kidney invigoration and sperm production preparation for treating oligospermatism and preparation method thereof | |
CN101810782B (en) | Medicament for treating diabetes | |
CN100391485C (en) | Medicine for treating diabetes and its preparation method | |
CN1072940C (en) | Oral liquid for anti-cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned | ||
C20 | Patent right or utility model deemed to be abandoned or is abandoned |